| J2357 | Injection, omalizumab, 5 mg | 10,370 | $30 | $310.9K |
| J2182 | Injection, mepolizumab, 1 mg | 11,800 | $20 | $271.4K |
| J0517 | Injection, benralizumab, 1 mg | 1,320 | $130 | $171.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 620 | $90 | $56.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 230 | $60 | $14.3K |
| 99457 | The provider manages treatment using data from remote physiologic monitoring. The service requires at least one real–time interactive communication with the patient or caregiver during the month and… | 350 | $40 | $13.1K |
| 99490 | The clinical staff provides services directed by the provider to support and coordinate a patient’s care across multiple disciplines. The patient has two or more chronic conditions that place the… | 280 | $50 | $12.9K |
| 99454 | The provider supplies one or more devices for remote physiologic monitoring that occurs for 16 to 30 days in a 30–day period. | 300 | $40 | $11.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 90 | $120 | $10.8K |
| 94729 | In this add on procedure, the provider tests the lungs’ diffusing capacity, the ability to exchange gases, moving oxygen into the bloodstream and letting in carbon dioxide from the bloodstream. | 210 | $40 | $8.9K |